TransMedics Group, Inc. (TMDX) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped TMDX stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: TransMedics Group has demonstrated exceptional growth potential and solid performance metrics, supported by strong product innovation and positive market outlooks. While recent stock volatility and patent-related risks remain a concern, the company's strategic initiatives and analyst confidence project a favorable growth trajectory. The stock offers significant upside in both medium and long-term horizons, particularly for investors seeking exposure to transformative medical technologies. The saved 1-year distribution is P10 $55, P50 $127, and P90 $160.
Last analyzed · Model: gpt-4o
TransMedics Group, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $55 | Pessimistic plausible scenario |
| P50 | $127 | Median scenario |
| P90 | $160 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
TransMedics Group has demonstrated significant growth potential, as indicated by its stellar revenue growth and strong recent earnings performance. The analyst consensus is highly positive, underscoring broad support from the financial community. However, the volatility in its stock price and ongoing patent challenges contribute to downside risks.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this TMDX analysis generated?
May 12, 2026.
Is this a guaranteed TMDX prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full TMDX stock analysis · TMDX sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.